Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

American Family Physician May 1, 2003 Distelhorst & Hughes	Open-Angle Glaucoma Glaucoma is a common cause of legal blindness in the US. Open-angle glaucoma is an asymptomatic, progressive optic neuropathy characterized by enlarging optic disc cupping and visual field loss. Without treatment, open-angle glaucoma can end in irreversible vision loss.
American Family Physician May 1, 2003	What Should I Know About Open-Angle Glaucoma? What is open-angle glaucoma?... Who gets open-angle glaucoma?... How can I find out if I have open-angle glaucoma?... How is open-angle glaucoma treated?... Where can I get more information?
BusinessWeek November 22, 2004 Carol Marie Cropper	Getting A Better Fix On Glaucoma A $50 pachymetry test improves diagnosis of the disease.
American Journal of Nursing February 2009 Sharts-Hopko & Glynn-Milley	Primary Open-Angle Glaucoma Primary open-angle glaucoma, by far the most common form of glaucoma, currently afflicts more than 2 million Americans, more than half of whom probably don't know they have it.
BusinessWeek October 18, 2004 Lewis Braham	Eye Surgery: It's Getting Sharper Laser eye surgery has improved, and newer techniques can fix trickier vision problems.
HHMI Bulletin Spring 2013 Julie Corliss	Pressure to See Clearly At the Jackson Laboratory in Bar Harbor, Maine, Simon John has spent nearly two decades honing tools to illuminate glaucoma's shadowy corners.
National Defense November 2009 Grace V. Jean	In the Eye of the Beholder: Contact Lenses as Displays and Sensors Scientists believe that the little plastic discs that hundreds of millions of people rely on to see clearer may one day serve military personnel and medical patients as information displays and health monitoring devices.
IEEE Spectrum October 2011 Joseph M. Smith	Wireless Health Care Wireless technologies are about to transform health care, and not a moment too soon
Pharmaceutical Executive April 1, 2012 Feam & Lagus	Providing Access Now While regulatory frameworks and medical practices differ between countries, many patients still need early access to new drugs. Industry can help.
AskMen.com Eric Huang	Eye Exams 101 Never had an eye exam? Call a specialist and book an appointment now. But read this first.
The Motley Fool May 30, 2006 Rich Duprey	NICE Not Playing Nice With Alzheimer's The British health authority proposes limiting availability of Alzheimer's treatments because of cost. What will this mean to drug-makers and their shareholders?
The Motley Fool September 7, 2010 Luke Timmerman	Vertex Nails Third Big Trial With Hepatitis C Drug And in the toughest patients to treat, too.
The Motley Fool March 28, 2008 Brian Orelli	The Yin and Yang of Schering's Label Changes Schering gets a pair of label changes that have opposite effects for its hepatitis C drug.
Pharmaceutical Executive June 1, 2006 Nancy Dreyer	Personalized Medicine Meets the Real World A wave of genomic medicines is coming down the pipeline, and they're going to be expensive. Can companies prove they're worth it? Maybe: but the claims payers seek aren't coming from traditional clinical trials.
The Motley Fool February 24, 2011 Brian Orelli	Profit From Personalized Medicine Pfizer's drug works well, but consider these companies instead.
Managed Care December 2000	Ease of navigating system varies by condition Do patients with differing conditions have different experiences within the health care system? A sampling of California patients suggests that they do...
BusinessWeek June 12, 2006 Michael Arndt	Big Pharma's Nurse Will See You Now Drug companies are hiring RNs to educate patients - and boost marketing.
BusinessWeek January 30, 2006 Catherine Arnst	Going Broke To Stay Alive Rising prices for cancer treatments are making patients - and doctors - balk.
The Motley Fool August 10, 2010 Ryan McBride	Vertex's Telaprevir Clears Hurdle, Could Halve Treatment Times for Hepatitis C Study results are positive.
Reason Aug/Sep 2007 Kerry Howley	Dying for Lifesaving Drugs Will desperate patients destroy the pharmaceutical system that produces tomorrow's treatments?
Managed Care May 2007 Rachel M. Renshaw	Keys to Diabetes Control? Patience, Persistence, and Perseverance Careful attention to a comprehensive treatment plan could forestall or prevent the need to add drugs and costs to a patient's regimen.
Pharmaceutical Executive November 1, 2008 George Koroneos	Tech Toys Here are the hottest gadgets and gizmos to make a dent in drug noncompliance.
Nursing June 2011 Daniel A. Hussar	New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis.
The Motley Fool August 29, 2011 Brian Orelli	Drug Approved for Few Patients -- but That's OK The age of personalized medicine is upon us. Earlier this month, the FDA approved Roche's melanoma drug Zelboraf for patients with a specific mutation in BRAF. And on Friday, the agency approved Pfizer's Xalkori for lung cancer patients that are ALK-positive.
Pharmaceutical Executive January 1, 2006 Gina Ashe	Alternative Media: Patient Bloggers on Your Brands Find out what patient bloggers are saying about your pharmaceutical brands.
BusinessWeek June 9, 2009 John Carey	Giving Patients the Data They Need A growing effort by doctors, insurers, and politicians helps people make better-informed medical decisions
The Motley Fool August 11, 2010 Brian Orelli	Dang! This Drug Is Shining Brighter Vertex illuminates telaprevir's additional benefit in treating hepatitis C patients.
Nursing June 2010 Daniel A. Hussar	New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs.
The Motley Fool March 30, 2009 Brian Orelli	Change the Game? Change the Rules! There are ways for investors to get around Obama's plan to lower health care costs. Investing in drug companies in this time of "change" doesn't have to be scary. You've just got to find rule breaker-type drugmakers, because playing by the rules isn't going to cut it anymore.
The Motley Fool September 8, 2010 Brian Orelli	You Must Realize This Drug Works by Now Vertex concludes its phase 3 trials with another win.
Nursing February 2010 Daniel A. Hussar	New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs.
Pharmaceutical Executive November 1, 2012 Sue Barrowcliffe	Real World Insights Commercial teams as well as patients can benefit from managed access programs, which are designed to provide access to medicines outside of the clinical and commercial setting, for patients who have no other available treatment options.
BusinessWeek May 29, 2006 John Carey	Medical Guesswork From heart surgery to prostate care, the health industry knows little about which common treatments really work.
American Family Physician May 15, 2001 Thomas J. McGinnis	Significant FDA Approvals in 2000 In 2000, the medical product review staffs of the U.S. Food and Drug Administration approved 160 new drugs, biologic products and medical devices for use in the United States. Many of these approvals advance the prevention, diagnosis and treatment of serious and life-threatening diseases...
AskMen.com Alex Santoso	5 Tips For Good Vision Health Because in the United States there are 300,000 men who are blind and 1.1 million men with impaired vision, here's a review of five things you can do for good vision health.
Nursing March 2010 Peg Gray-Vickrey	Gathering pearls of knowledge for assessing older adults If you attended nursing school more than 10 years ago, you may have received limited education about gerontological nursing. But as baby boomers age, this is becoming an increasingly important area of nursing practice.
The Motley Fool May 28, 2004 Charly Travers	Don't Be a Biotech Gambler Stand on solid ground by learning to assess the value of future drug programs. Investing in biotechs -- rather than simply speculating in the sector -- requires a solid assessment of how much a company's drug programs could be worth.
Pharmaceutical Executive November 1, 2012 Lauri Mitchell	Who Pays for Specialty Medicines? Providers and patients fish for that delicate balance between access and abandonment.
Pharmaceutical Executive August 1, 2008 George Koroneos	Hard of (Ad)hering Companies have responded to declining profits with a proliferation of patient compliance programs. But where is pharma in this paradigm shift?
Fast Company Alice Truong	What If Google Glass Came In The Form Of A Contact Lens? One of the major complaints against Google's futuristic heads-up display is that it's so obvious -- even with redesigned specs.
Pharmaceutical Executive June 1, 2009 Michael Maher	Learning to Relate A multi-phase implementation strategy can debunk the myth that social media won't work for pharma.
Wired March 2006 Jennifer Kahn	A Nation of Guinea Pigs There's a new outsourcing boom in South Asia - and a billion people are jockeying for the jobs. How India became the global hot spot for drug trials.
Pharmaceutical Executive July 30, 2007 Louis A. Morris	Safety Net The new Culture of Drug Safety means embracing the benefit of no doubt about a product's pluses and its minuses. Pharma must learn how patients and prescribers weigh risks and how to spread the word about the advantages.
American Family Physician October 15, 2002 Mahesh Krishnan	Preoperative Care of Patients with Kidney Disease Preoperative attention to common medical problems that occur in patients with impaired renal function can lower some surgical risks.
Pharmaceutical Executive May 1, 2005 Ame Wadler	PR: In the Loop Pharma marketers can help doctors stay abreast of the news.
Pharmaceutical Executive May 1, 2009 Maryann Kuzel	Weathering the Storm Marketers must stress that maintaining good health behaviors is one of the best things people can do to survive a down market.
IEEE Spectrum June 2008 Neil Savage	Chip for Future Eye Implants Runs on Picowatts, Thanks to New Deep-Sleep Tech Chip could run for a year on millimeter-sized battery.
Inc. October 1, 2009 Adam Bluestein	The Future of the Human Body Ten innovations that will improve quality of life - and bring down health care costs.
Fast Company April 2012 Christina Chaey	Srikant Iyer Streamlines Patient Care In Hectic Emergency Rooms This health-care innovator uses a different kind of triage system to identify who is very ill and who is mildly ill, keeping emergency room care moving.
Pharmaceutical Executive January 1, 2006 Maggie Helmig	Direct to Consumer: Patient Education Reform Marketers can empower patients to start a dialogue with their doctors.